Evidence that a novel transdiagnostic eating disorder treatment reduces reward region response to the thin beauty ideal and high-calorie binge foods
Assessed by RV005 · Statistician
Assessed on 11 Nov 2025
OverallReviewer's overall integrity assessment, derived from all research questions No concerns
DOI 10.1017/s0033291721004049 (opens in new tab)
Resource ripekg:research-integrity-assessment/RIPEA11857BB03F7C3515
5 Research Questions · 2 Evidence Items
Q1.1 — Does the study have an associated retraction?
Rationale: Agreed
Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?
Rationale: Agreed
Q1.3 — Do other studies by the research team highlight causes for concern?
Rationale: Agreed
Q2.2 — Are there concerns relating to the timing or absence of study registration?
Rationale: Agreed
Supporting Evidence (2)
Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)
No trial registration found
Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates LLM-extracted recruitment start date (normalized_date) is missing or empty.
Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text
Recruitment Start: N/A
Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date No recruitment start date found.
Recruitment End: N/A
Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date No recruitment end date found.
Study End: N/A
Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date No study end date found.
Overall — What is the overall integrity assessment of the study?
Rationale: Overall I would not be too concerned, but am unaware that items such as registration ID are pertinent to report in papers if they are (hopefully) available elsewhere.